The Chemours Company (CC) Investor presentation summary

Business overview

• Operates three main segments: Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), with a global presence and diversified product portfolio including Opteon, Freon, Ti-Pure, Teflon, Nafion, Viton, and Krytox.

• Net sales for 2025 were $5.8B with Adjusted EBITDA of $742M; North America accounted for 46% of sales, followed by EMEA (20%), Asia Pacific (21%), and Latin America (13%).

• TSS segment led by Opteon refrigerants, benefiting from regulatory trends and innovation in liquid cooling for data centers.

• TT segment is a global leader in TiO2 production, focusing on cost leadership and operational flexibility.

• APM segment targets high-growth specialty applications, with a diverse customer base and focus on advanced materials.

Strategic progress

• Achieved $125M in cost savings in 2025 and advanced operational excellence initiatives, including Lean principles and manufacturing center of excellence.

• Delivered double-digit growth in Opteon refrigerants (37% YoY in Q4, 56% for full year), and implemented global TiO2 price increases.

• Progressed portfolio management with asset sales (e.g., Kuan Yin TiO2 site for $360M gross, ~$300M net) and exited non-core businesses.

• Advanced innovation in liquid cooling, with successful qualification of two-phase immersion cooling fluid by Samsung Electronics.

• Resolved significant legacy liabilities, including a comprehensive PFAS settlement with New Jersey, minimizing out-of-pocket payments through 2030.

Financial performance

• FY25 net sales were $5.8B, Adjusted EBITDA $742M, and Adjusted Net Income $143M; reported net loss of $386M due to litigation and other non-recurring items.

• Free cash flow for 2025 was $51M, with a 7% FCF conversion rate; significant improvement from negative FCF in 2024.

• Q4 2025 net sales were $1.3B, Adjusted EBITDA $128M, and free cash flow $92M.

• TSS segment delivered 32% Adjusted EBITDA margin in 2025, TT margin was 6%, and APM margin was 9%.

• Liquidity at year-end was $1.6B, with $670M unrestricted cash and net leverage of 4.7x.